Receptor selective cannabimimetic aminoalkylindoles

Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S001110, C424S001650, C424S001810, C424S001850, C424S001890, C424S009100, C424S009300

Reexamination Certificate

active

07820144

ABSTRACT:
Disclosed are cannabimimetic aminoalkylindole compounds and methods for their manufacture. The disclosed compounds are surprisingly potent and selective cannabinoids. The disclosed compounds may include radioactive atoms. Also disclosed are methods of using the disclosed compounds, including use of the disclosed compounds to stimulate a cannabinoid receptor, to provide a physiological effect in an animal or individual, to treat a condition in an animal or individual and for use in radioimaging.

REFERENCES:
patent: 6900236 (2005-05-01), Makriyannis et al.
patent: 7173027 (2007-02-01), Makriyannis et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Receptor selective cannabimimetic aminoalkylindoles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Receptor selective cannabimimetic aminoalkylindoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Receptor selective cannabimimetic aminoalkylindoles will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4191074

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.